Wikidata

(Q62817401)

English

A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

clinical trial

In more languages

Statements

title
A Randomized, Double-blind, Placebo-controlled Multicenter Dose Ranging Study to Assess the Safety and Efficacy of Multiple Oral ZPL389 Doses in Patients With Moderate to Severe Atopic Dermatitis (ZEST Trial) (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
sponsor
Novartis
0 references
country
Canada
0 references
Finland
0 references
Germany
0 references
Iceland
0 references
Japan
0 references
Netherlands
0 references
Poland
0 references
United Kingdom
0 references
start time
14 November 2018
0 references
end time
16 March 2020
0 references
number of participants
360
0 references
research site
Novartis
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62817401&oldid=1857080421"